Open AccessHepatocellular Carcinoma: Basic and Transitional Research
Author(s) -
Chuan Yin,
WeiFen Xie
Publication year - 2014
Publication title -
gastrointestinal tumors
Language(s) - English
Resource type - Journals
eISSN - 2296-3766
pISSN - 2296-3774
DOI - 10.1159/000362579
Subject(s) - sorafenib , targeted therapy , hepatocellular carcinoma , medicine , erlotinib , cancer research , tyrosine kinase , cancer , oncology , epidermal growth factor receptor , receptor
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. The outcome of HCC therapy depends on the stage of HCC. Early-stage HCC patients can be cured with radical treatment approaches, whereas no standard treatment regimens can be recommended for patients with advanced disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom